Literature DB >> 17205826

[Toxicity attenuation and efficacy potentiation effect of liquorice on treatment of rheumatoid arthritis with Tripterygium wilfordii].

Ya-Song Li1, Pei-Jian Tong, Hong-Zhen Ma.   

Abstract

OBJECTIVE: To investigate the toxicity attenuation and efficacy potentiation effect of liquorice on treatment of rheumatoid arthritis (RA) with Tripterygium wilfordii (TW).
METHODS: One hundred and twenty RA patients were randomly assigned to two groups: the treated group treated with compound decoctum of TW and liquorice and the control group with TW ployglycosidium tablets both based on routine treatment. The therapeutic effect and adverse reaction were observed after 2 months of treatment.
RESULTS: The total efficacy rate was 89.8% in the treated group and 79.6% in the control group with insignificant difference between the two groups; the effect was better in the treated group than that of the control group in decreasing the swollen joint index and increasing the average grip strength of both hands (P < 0.05); the total incidence of adverse reaction was obviously lower in the treated group than that of the control (P < 0.01).
CONCLUSION: Liquorice has toxicity attenuation and efficacy potentiation effect on treatment of RA with TW.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17205826

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  8 in total

Review 1.  Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects.

Authors:  Cong-Ying Song; Ying-Ge Xu; Yuan-Qiang Lu
Journal:  J Zhejiang Univ Sci B       Date:  2020 Apr.       Impact factor: 3.066

2.  Anti-inflammatory effects of licorice and roasted licorice extracts on TPA-induced acute inflammation and collagen-induced arthritis in mice.

Authors:  Ki Rim Kim; Chan-Kwon Jeong; Kwang-Kyun Park; Jong-Hoon Choi; Jung Han Yoon Park; Soon Sung Lim; Won-Yoon Chung
Journal:  J Biomed Biotechnol       Date:  2010-03-17

3.  The Protective Effects of Isoliquiritigenin and Glycyrrhetinic Acid against Triptolide-Induced Oxidative Stress in HepG2 Cells Involve Nrf2 Activation.

Authors:  Ling-Juan Cao; Huan-De Li; Miao Yan; Zhi-Hua Li; Hui Gong; Pei Jiang; Yang Deng; Ping-Fei Fang; Bi-Kui Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-21       Impact factor: 2.629

4.  The Ethanol Extract of Licorice (Glycyrrhiza uralensis) Protects against Triptolide-Induced Oxidative Stress through Activation of Nrf2.

Authors:  Ling-Juan Cao; Zhen-Yan Hou; Huan-De Li; Bi-Kui Zhang; Ping-Fei Fang; Da-Xiong Xiang; Zhi-Hua Li; Hui Gong; Yang Deng; Yan-Xia Ma; Huai-Bo Tang; Miao Yan
Journal:  Evid Based Complement Alternat Med       Date:  2017-09-26       Impact factor: 2.629

Review 5.  Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis.

Authors:  Xin Pan; Maria A Lopez-Olivo; Juhee Song; Gregory Pratt; Maria E Suarez-Almazor
Journal:  BMJ Open       Date:  2017-03-01       Impact factor: 2.692

6.  Protective Effect of 18β-Glycyrrhetinic Acid against Triptolide-Induced Hepatotoxicity in Rats.

Authors:  Guanghua Yang; Lan Wang; Xiuting Yu; Yanfeng Huang; Chang Qu; Zhenbiao Zhang; Dandan Luo; Ji Lin; Lian Zhou; Ziren Su; Xiaojun Zhang; Haiming Chen
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-09       Impact factor: 2.629

Review 7.  [Thermo-chemotherapy of GP or TP for advanced non-small cell lung cancer: a systematic review].

Authors:  Denghai Mi; Zheng Li; Kehu Yang; Nong Cao; Jinhui Tian; Bin Ma
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-08

8.  Adverse Events Associated With Treatment of Tripterygium wilfordii Hook F: A Quantitative Evidence Synthesis.

Authors:  Yi Ru; Ying Luo; Yaqiong Zhou; Le Kuai; Xiaoying Sun; Meng Xing; Liu Liu; Yi Lu; Seokgyeong Hong; Xi Chen; Jiankun Song; Yue Luo; Xiaoya Fei; Bin Li; Xin Li
Journal:  Front Pharmacol       Date:  2019-11-06       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.